GILDER GAGNON HOWE & CO LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$4,281,652
-12.6%
238,532
-1.1%
0.06%
-3.0%
Q2 2023$4,898,552
+17.7%
241,189
+5.7%
0.07%
-2.9%
Q1 2023$4,160,748
-15.8%
228,111
-4.5%
0.07%
-25.0%
Q4 2022$4,939,194
-21.7%
238,839
-1.0%
0.09%
-16.4%
Q3 2022$6,311,000
+12.1%
241,227
+8.6%
0.11%
+10.0%
Q2 2022$5,628,000
-38.8%
222,082
-23.8%
0.10%
+17.6%
Q1 2022$9,193,000
-22.4%
291,280
-0.5%
0.08%
+26.9%
Q4 2021$11,844,000
+16.7%
292,668
+0.6%
0.07%
+26.4%
Q3 2021$10,147,000
+24.4%
291,003
-2.0%
0.05%
+32.5%
Q2 2021$8,158,000
-4.5%
297,088
-2.3%
0.04%
-13.0%
Q1 2021$8,542,000
+4.2%
304,212
-3.7%
0.05%
+12.2%
Q4 2020$8,198,000
-45.1%
315,811
-63.7%
0.04%
-55.4%
Q3 2020$14,923,000
-25.1%
870,634
+8.1%
0.09%
-41.0%
Q2 2020$19,918,000
+7039.1%
805,074
+3899.4%
0.16%
+5100.0%
Q1 2020$279,000
+29.2%
20,130
-5.7%
0.00%
+50.0%
Q4 2019$216,000
+13.7%
21,356
+2.1%
0.00%0.0%
Q3 2019$190,000
+16.6%
20,915
+2.3%
0.00%0.0%
Q2 2019$163,00020,4430.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders